Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome

JAMA Psychiatry

Volumn 72, Issue 4, 2015, Pages 377-385

  Vorstman, Jacob A S ^a   Breetvelt, Elemi J ^a   Duijff, Sasja N ^a   Eliez, Stephan ^b   Schneider, Maude ^b   Jalbrzikowski, Maria ^c,d   Armando, Marco ^e   Vicari, Stefano ^e   Shashi, Vandana ^f   Hooper, Stephen R ^g   Chow, Eva W C ^h,i   Fung, Wai Lun Alan ^h,i,j   Butcher, Nancy J ^h,k   Young, Donald A ^h,i   McDonald McGinn, Donna M ^l   Vogels, Annick ^m   Van Amelsvoort, Therese ⁿ   Gothelf, Doron ^o,p   Weinberger, Ronnie ^o,p   Weizman, Abraham ^p,q   Klaassen, Petra W J ^r   Koops, Sanne ^a   Kates, Wendy R ^s   Antshel, Kevin M ^s,t   Simon, Tony J ^u   Ousley, Opal Y ^v   Swillen, Ann ^m   Gur, Raquel E ^w   Bearden, Carrie E ^c,d   Kahn, René S ^a   Bassett, Anne S ^h,i,j   Emanuel, Beverly S ^w   Zackai, Elaine H ^l   Kushan, Leila ^c   Fremont, Wanda ^x   Schoch, Kelly ^f   Stoddard, Joel ^u   Cubells, Joseph ^v   Fu, Fiona ⁱ   Campbell, Linda E ^y   Fritsch, Rosemarie ^z   Vergaelen, Elfi ^m   Neeleman, Marjolein ^a   Boot, Erik ^aa   Debbané, Martin ^b   Philip, Nicole ^ab   Green, Tamar ^p,ac   Van DenBree, Marianne B M ^ad   Murphy, Declan ^ae   Canyelles, Jaume Morey ^af   Arango, Celso ^ag   Murphy, Kieran C ^ah   Pontillo, Maria ^e   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY HEALTH NETWORK   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

^l CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^m UNIVERSITY OF LEUVEN   (Belgium)

ⁿ MAASTRICHT UNIVERSITY   (Netherlands)

^o SHEBA MEDICAL CENTER   (Israel)

^p TEL AVIV UNIVERSITY   (Israel)

^q GEHA MENTAL HEALTH CENTER   (Israel)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s STATE UNIVERSITY OF NEW YORK   (United States)

^t SYRACUSE UNIVERSITY   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^w UNIVERSITY OF PENNSYLVANIA   (United States)

^x SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^y UNIVERSITY OF NEWCASTLE   (Australia)

^z UNIVERSITY OF CHILE   (Chile)

^aa ACADEMIC MEDICAL CENTER   (Netherlands)

^ab CNRS   (France)

^ac STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ad CARDIFF UNIVERSITY   (United Kingdom)

^ae KING'S COLLEGE LONDON   (United Kingdom)

^af HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^ag HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^ah ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME DELETION 22Q11; COGNITIVE DEFECT; COHORT ANALYSIS; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PSYCHOSIS; WECHSLER INTELLIGENCE SCALE; AGE; CHROMOSOME 22; COMPLICATION; DIGEORGE SYNDROME; GENETICS; INTELLIGENCE TEST; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; CHILD; CHROMOSOMES, HUMAN, PAIR 22; COGNITION DISORDERS; DIGEORGE SYNDROME; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISK FACTORS; YOUNG ADULT;

EID: 84928322367     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.2671     Document Type: Article

References (63)

1. Kraepelin E. Dementia Praecox and Paraphrenia. Barclay RM, trans. Robertson GM, ed. Chicago, IL: Chicago Medical Book Co; 1919
2. Reichenberg A,Weiser M, Rapp MA, et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry. 2005; 62(12):1297-1304
3. Cannon TD, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T. Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull. 2000;26(2):379-393
4. Bearden CE, Rosso IM, Hollister JM, Sanchez LE, Hadley T, Cannon TD. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia. Schizophr Bull. 2000;26(2):395-410
5. Cannon M, Caspi A, Moffitt TE, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002;59(5):449-456
6. Fuller R, Nopoulos P, Arndt S, O'Leary D, Ho BC, Andreasen NC. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry. 2002;159(7):1183-1189
7. Rabinowitz J, De Smedt G, Harvey PD, Davidson M. Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis.AmJ Psychiatry. 2002;159(12):2021-2026
8. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: ameta-analytic review. Am J Psychiatry. 2008;165(5):579-587
9. Keefe RS, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res. 2006;88(1-3):26-35
10. Cosway R, Byrne M, Clafferty R, et al. Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med. 2000;30(5):1111-1121
11. Meier MH, Caspi A, Reichenberg A, et al. Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry. 2014;171(1):91-101
12. Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70(10):1107-1112
13. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56(10):940-945
14. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardiofacial syndrome.AmJ Med Genet. 1992;42(1):141-142
15. Vorstman JA, Morcus ME, Duijff SN, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J AmAcad Child Adolesc Psychiatry. 2006;45(9): 1104-1113
16. Schneider M, Debbane M, Bassett AS, et al; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. AmJ Psychiatry. 2014;171(6):627-639
17. Edelmann L, Pandita RK, Spiteri E, et al. A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet. 1999;8(7):1157-1167
18. Shaikh TH, Kurahashi H, Saitta SC, et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet. 2000;9(4):489-501
19. Karayiorgou M, Simon TJ, Gogos JA. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci. 2010;11(6):402-416
20. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J,Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003;160(9):1580-1586
21. Chow EW,WatsonM, Young DA, Bassett AS. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res. 2006;87(1-3): 270-278
22. van Amelsvoort T, Henry J, Morris R, et al. Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res. 2004;70(2-3):223-232
23. Yuen T, Chow EW, Silversides CK, Bassett AS. Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome. Schizophr Res. 2013;151(1-3):221-225
24. Green T, Gothelf D, Glaser B, et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J AmAcad Child Adolesc Psychiatry. 2009;48(11):1060-1068
25. Gothelf D, Eliez S, Thompson T, et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci. 2005;8(11):1500-1502
26. Kates WR, Antshel KM, Faraone SV, et al. Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry. 2011;69(10):945-952
27. Gothelf D, Schneider M, Green T, et al. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. J Am Acad Child Adolesc Psychiatry. 2013;52(11):1192-1203.e3
28. Lane EA, Albee GW. On childhood intellectual decline of adult schizophrenics: a reassessment of an earlier study. J Abnorm Psychol. 1968;73(2):174-177
29. Bos K. Relationship between cognitive development, decoding skill, and reading comprehension in learning-disabled Dutch children. In: Aaron PG, Joshi RM, eds. Reading andWriting Disorders in Different Orthographic Systems. Vol 52. Houten, the Netherlands: Springer Netherlands; 1989:75-86
30. Share DL, Silva PA. Language deficits and specific reading retardation: cause or effect? Br J Disord Commun. 1987;22(3):219-226
31. Shaywitz BA, Holford TR, Holahan JM, et al. A Matthew effect for IQ but not for reading: results from a longitudinal study. Read Res Q. 1995;30(4): 894-906
32. Duijff SN, Klaassen PW, de Veye HF, Beemer FA, Sinnema G, Vorstman JA. Cognitive development in children with 22q11.2 deletion syndrome. Br J Psychiatry. 2012;200(6):462-468
33. Wechsler D.Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: Psychological Corp; 1991.
34. Wechsler D.Wechsler Preschool and Primary Scale of Intelligence. 3rd ed. San Antonio, TX: Psychological Corp; 2002
35. Wechsler D.Wechsler Intelligence Scale for Children. 4th ed. San Antonio, TX: Psychological Corp; 2003.
36. Wechsler D.Wechsler Adult Intelligence Scale. 4th ed. San Antonio, TX: Psychological Corp; 2008
37. Habel A, McGinn MJ II, Zackai EH, Unanue N, McDonald-McGinn DM. Syndrome-specific growth charts for 22q11.2 deletion syndrome in Caucasian children.AmJMed Genet A. 2012;158A(11):2665-2671
38. Myrelid A, Gustafsson J, Ollars B, Anneren G. Growth charts for Down's syndrome from birth to 18 years of age. Arch Dis Child. 2002;87(2):97-103
39. van Buuren S, FredriksM.Worm plot: a simple diagnostic device for modelling growth reference curves. Stat Med. 2001;20(8):1259-1277
40. Schaer M, Debbane M, Bach CuadraM, et al. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study. Schizophr Res. 2009;115(2-3):182-190
41. Chow EW, Ho A,Wei C, Voormolen EH, Crawley AP, Bassett AS. Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus. Am J Psychiatry. 2011;168(5):522-529
42. da Silva Alves F, Schmitz N, Bloemen O, et al. White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia. Schizophr Res. 2011;132(1):75-83
43. Raux G, Bumsel E, Hecketsweiler B, et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet. 2007;16(1):83-91
44. Vorstman JA, Turetsky BI, Sijmens-Morcus ME, et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology. 2009;34(3):739-746
45. Magnee MJ, Lamme VA, de Sain-van der Velden MG, Vorstman JA, Kemner C. Proline and COMT status affect visual connectivity in children with 22q11.2 deletion syndrome. PLoS One. 2011;6 (10):e25882
46. Williams NM, Glaser B, Norton N, et al. Strong evidence that GNB1L is associated with schizophrenia. Hum Mol Genet. 2008;17(4):555-566
47. Vorstman JA, Chow EW, Ophoff RA, et al. Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(3):430-433
48. Gothelf D, Feinstein C, Thompson T, et al. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry. 2007;164(4):663-669
49. Zammit S, Allebeck P, David AS, et al. A longitudinal study of premorbid IQscore and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry. 2004;61(4):354-360
50. Dickson H, Laurens KR, Cullen AE, Hodgins S. Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia. Psychol Med. 2012;42(4): 743-755
51. van Oel CJ, Sitskoorn MM, Cremer MP, Kahn RS. School performance as a premorbid marker for schizophrenia: a twin study. Schizophr Bull. 2002; 28(3):401-414
52. Reichenberg A, Caspi A, Harrington H, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry. 2010;167(2):160-169
53. Dekker MC, Koot HM, van der Ende J, Verhulst FC. Emotional and behavioral problems in children and adolescents with and without intellectual disability. J Child Psychol Psychiatry. 2002;43(8): 1087-1098
54. Koenen KC, Moffitt TE, Roberts AL, et al. Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am J Psychiatry. 2009;166(1):50-57
55. Gale CR, Deary IJ, Boyle SH, Barefoot J, Mortensen LH, Batty GD. Cognitive ability in early adulthood and risk of 5 specific psychiatric disorders inmiddle age: the Vietnam experience study. Arch Gen Psychiatry. 2008;65(12):1410-1418
56. Baker K, Vorstman JA. Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome? Curr Opin Neurol. 2012;25(2):131-137
57. Tang SX, Yi JJ, Calkins ME, et al. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol Med. 2014;44 (6):1267-1277
58. Duijff SN, Klaassen PW, Swanenburg de Veye HF, Beemer FA, Sinnema G, Vorstman JA. Cognitive and behavioral trajectories in 22q11DS from childhood into adolescence: a prospective 6-year follow-up study. Res Dev Disabil. 2013;34(9):2937-2945
59. Hedman AM, van Haren NE, van Baal CG, Kahn RS, Hulshoff Pol HE. IQ change over time in schizophrenia and healthy individuals: ameta-analysis. Schizophr Res. 2013;146(1-3):201-208
60. Insel TR. Rethinking schizophrenia. Nature. 2010;468(7321):187-193
61. Pukrop R, Ruhrmann S, Schultze-Lutter F, Bechdolf A, Brockhaus-Dumke A, Klosterkotter J. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr Res. 2007;92(1-3):116-125
62. Evers LJ, van Amelsvoort TA, Candel MJ, Boer H, Engelen JJ, Curfs LM. Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability. J Intellect Disabil Res. 2014;58(10):915-925
63. Kaufman AS, Lichtenberger OL. Assessing Adolescent and Adult Intelligence. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2006.